Search research articles
Contact Us
Filters
Showing results (61-70 of 71) with videos related to
Page
of 8
Sort By:
Neuropathology and Applied Neurobiology
|
May 12, 2007
De novo erythropoietin receptor (EPO-R) expression in human neoplastic glial cells decreases with grade of malignancy but is favourably associated with patient survival
M Mittelbronn, D Capper, B Bunz, et al.
ESMO Open
|
October 20, 2023
Leptomeningeal metastasis from solid tumours: EANO-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
E Le Rhun, M Weller, M van den Bent, et al.
Oncogene
|
May 8, 2012
Suppression of proinvasive RGS4 by mTOR inhibition optimizes glioma treatment
M Weiler, P-N Pfenning, A-L Thiepold, et al.
European Journal of Neurology
|
August 20, 2010
Guidelines on management of low-grade gliomas: report of an EFNS-EANO Task Force
R Soffietti, B G Baumert, L Bello, et al.
BMC Cancer
|
June 12, 2022
Improvement of functional outcome for patients with newly diagnosed grade 2 or 3 gliomas with co-deletion of 1p/19q - IMPROVE CODEL: the NOA-18 trial
A Wick, A Sander, M Koch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 27, 2020
Neurological and vascular complications of primary and secondary brain tumours: EANO-ESMO Clinical Practice Guidelines for prophylaxis, diagnosis, treatment and follow-up
P Roth, A Pace, E Le Rhun, et al.
Acta Neuropathologica Communications
|
April 27, 2019
DNA methylation, transcriptome and genetic copy number signatures of diffuse cerebral WHO grade II/III gliomas resolve cancer heterogeneity and development
H Binder, E Willscher, H Loeffler-Wirth, et al.
Neuropathology and Applied Neurobiology
|
October 17, 2018
Integrated molecular characterization of IDH-mutant glioblastomas
A Korshunov, B Casalini, L Chavez, et al.
Journal of Neuropathology and Experimental Neurology
|
June 13, 2000
Comprehensive allelotype and genetic anaysis of 466 human nervous system tumors
A von Deimling, R Fimmers, M C Schmidt, et al.
Journal of Neuro-Oncology
|
January 8, 2014
NDRG1 prognosticates the natural course of disease in WHO grade II glioma
J Blaes, M Weiler, F Sahm, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 71) with videos related to
Sort By:
Page
of 8
Neuropathology and Applied Neurobiology
|
May 12, 2007
De novo erythropoietin receptor (EPO-R) expression in human neoplastic glial cells decreases with grade of malignancy but is favourably associated with patient survival
M Mittelbronn, D Capper, B Bunz, et al.
ESMO Open
|
October 20, 2023
Leptomeningeal metastasis from solid tumours: EANO-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
E Le Rhun, M Weller, M van den Bent, et al.
Oncogene
|
May 8, 2012
Suppression of proinvasive RGS4 by mTOR inhibition optimizes glioma treatment
M Weiler, P-N Pfenning, A-L Thiepold, et al.
European Journal of Neurology
|
August 20, 2010
Guidelines on management of low-grade gliomas: report of an EFNS-EANO Task Force
R Soffietti, B G Baumert, L Bello, et al.
BMC Cancer
|
June 12, 2022
Improvement of functional outcome for patients with newly diagnosed grade 2 or 3 gliomas with co-deletion of 1p/19q - IMPROVE CODEL: the NOA-18 trial
A Wick, A Sander, M Koch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 27, 2020
Neurological and vascular complications of primary and secondary brain tumours: EANO-ESMO Clinical Practice Guidelines for prophylaxis, diagnosis, treatment and follow-up
P Roth, A Pace, E Le Rhun, et al.
Acta Neuropathologica Communications
|
April 27, 2019
DNA methylation, transcriptome and genetic copy number signatures of diffuse cerebral WHO grade II/III gliomas resolve cancer heterogeneity and development
H Binder, E Willscher, H Loeffler-Wirth, et al.
Neuropathology and Applied Neurobiology
|
October 17, 2018
Integrated molecular characterization of IDH-mutant glioblastomas
A Korshunov, B Casalini, L Chavez, et al.
Journal of Neuropathology and Experimental Neurology
|
June 13, 2000
Comprehensive allelotype and genetic anaysis of 466 human nervous system tumors
A von Deimling, R Fimmers, M C Schmidt, et al.
Journal of Neuro-Oncology
|
January 8, 2014
NDRG1 prognosticates the natural course of disease in WHO grade II glioma
J Blaes, M Weiler, F Sahm, et al.
Page
of 8